Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol and travoprost therapy in primary open-angle glaucoma
ACTRN12612000247875Phase 4Recruiting
- Sponsor
- Luigi Mazzeo
- Start
- Feb 2011
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of timolol and travoprost in open-angle glaucoma (OAG) and ocular hypertension (3 arms), sponsored by Luigi Mazzeo. Primary endpoint: Reduction in intraocular pressure with different eye drop combinations. Started Feb 2011; status: recruiting.
02
Drugs
timololtravoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on ACTRN12612000247875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000247875.